A compound can be widely discussed and still rest almost entirely on cell-culture and animal data, with little or no controlled human evidence
Raun K, Hansen BS, Johansen NL, et al.: Ipamorelin, the first selective growth hormone secretagogue
Many protocols combine both approaches for maximum effect, typically running 12 to 16 weeks minimum before visible density changes become apparent
HGF/c-Met pathway is one of the most dysregulated pathways in human malignancies, which include, but are not limited to: bladder, breast, cervical, colorectal, endometrial, esophageal, gastric, head and neck, kidney, liver, lung, nasopharyngeal, ovarian, pancreatic, prostate, and thyroid cancers ( Activation of Met in cancer occurs most often through ligand autocrine or paracrine activation
Lipo MICC + B12 injections are generally well tolerated